These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16573296)

  • 1. Antenatal modes of surfactant administration for RDS prevention: a review.
    Ostrzenski A; Radolinski B; Ostrzenska KM
    J Natl Med Assoc; 2006 Mar; 98(3):340-4. PubMed ID: 16573296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surfactant administration to the human fetus in utero: a new approach to prevention of neonatal respiratory distress syndrome (RDS).
    Cosmi EV; La Torre R; Di Iorio R; Anceschi MM
    J Perinat Med; 1996; 24(2):191-3. PubMed ID: 8773946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intraamniotic surfactant supply as RDS prevention].
    Lisawa J; Pietrasik D; Zwoliński J; Gierowska-Bogusz B; Lewandowski L; Chazan B
    Med Wieku Rozwoj; 2003; 7(3 Suppl 1):255-60. PubMed ID: 15537270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroids and surfactant for prevention of neonatal RDS.
    Robertson B
    Ann Med; 1993 Jun; 25(3):285-8. PubMed ID: 8333929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraamniotic surfactant for prevention of neonatal respiratory distress syndrome (IRDS): rationale and personal experience.
    Cosmi EV; La Torre R; Piazze JJ; Maranghi GL; Lerro N; Bianco D; Anceschi MM
    Eur J Obstet Gynecol Reprod Biol; 1997 Feb; 71(2):135-9. PubMed ID: 9138955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined hormonal therapy for the prevention of respiratory distress syndrome and its consequences.
    Moya FR; Gross I
    Semin Perinatol; 1993 Aug; 17(4):267-74. PubMed ID: 8140441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intra-amniotic administration of Exosurf in preterm rabbit fetuses.
    Galan HL; Kuehl TJ
    Obstet Gynecol; 1992 Oct; 80(4):604-8. PubMed ID: 1407880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-amniotic instillation of surfactants for the prevention of neonatal respiratory distress syndrome following preterm delivery.
    Agarwal N; Bathwal S; Kriplani A; Deorari A; Bhatla N
    Int J Gynaecol Obstet; 2016 Nov; 135(2):196-199. PubMed ID: 27594379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal respiratory distress syndrome and surfactant therapy; a brief review.
    Robertson B
    Eur Respir J Suppl; 1989 Mar; 3():73s-76s. PubMed ID: 2662999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surfactant sufficiency for immature infants--prenatal induction vs. postnatal treatment.
    Taeusch HW; Smith BT
    Eur J Respir Dis Suppl; 1987; 153():249-54. PubMed ID: 3480820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dilemmas about the antenatal use of corticosteroids for prevention of neonatal morbidity and mortality].
    Grgić O; Matijević R
    Acta Med Croatica; 2005; 59(2):129-35. PubMed ID: 15909887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimally invasive approaches for surfactant administration.
    Trevisanuto D; Marchetto L
    Acta Biomed; 2013; 84 Suppl 1():28-31. PubMed ID: 24049959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of fetal pulmonary aspiration of intra-amniotic administered surfactant in animal experiment.
    Illia R; Solana C; Oliveri P; Toblli J; Imaz MU; Häbich D
    J Perinat Med; 2004; 32(4):354-8. PubMed ID: 15346823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In utero surfactant administration to preterm human fetuses using endoscopy.
    Petrikovsky BM; Lysikiewicz A; Markin LB; Slomko Z
    Fetal Diagn Ther; 1995; 10(2):127-30. PubMed ID: 7794513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effects of antenatal corticosteroids and surfactant supplementation on the outcome of very low birth weight infants.
    Modanlou HD; Beharry K; Padilla G; Iriye B
    J Perinatol; 1996; 16(6):422-8; quiz 429-30. PubMed ID: 8979178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early versus delayed surfactant administration in extremely premature neonates with respiratory distress syndrome ventilated by high-frequency oscillatory ventilation.
    Plavka R; Kopecký P; Sebron V; Leiská A; Svihovec P; Ruffer J; Dokoupilová M; Zlatohlávková B; Janus V; Keszler M
    Intensive Care Med; 2002 Oct; 28(10):1483-90. PubMed ID: 12373475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surfactant administration during spontaneous breathing via a thin endotracheal catheter.
    Martinelli S; Gatelli I; Proto A
    Acta Biomed; 2013; 84 Suppl 1():22-4. PubMed ID: 24049957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimally invasive surfactant administration in preterm infants: a meta-narrative review.
    More K; Sakhuja P; Shah PS
    JAMA Pediatr; 2014 Oct; 168(10):901-8. PubMed ID: 25089718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of a prolonged time interval between antenatal corticosteroid administration and delivery on outcomes in preterm neonates: a cohort study.
    Ring AM; Garland JS; Stafeil BR; Carr MH; Peckman GS; Pircon RA
    Am J Obstet Gynecol; 2007 May; 196(5):457.e1-6. PubMed ID: 17466700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation.
    Kattwinkel J; Bloom BT; Delmore P; Davis CL; Farrell E; Friss H; Jung AL; King K; Mueller D
    Pediatrics; 1993 Jul; 92(1):90-8. PubMed ID: 8516091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.